EC Healthcare (HK:2138) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
EC Healthcare reported a mixed sales performance for the six months ending September 2024, with an overall sales volume decrease of up to 4% year-on-year, impacted by a significant 49% drop in aesthetic medical and wellness services in Mainland China. However, the company saw a promising 12% increase in sales volume from other services, highlighting diverse growth opportunities amidst a challenging market environment.
For further insights into HK:2138 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue